- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Theratechnologies Inc
+ Add to WatchlistTHERF:US
0.2500 USD 0.00000.00%As of 20:10:00 ET on 05/17/2013.
Snapshot for Theratechnologies Inc (THERF)
| Open: | 0.2502 | Day's Range: | 0.2430 - 0.2502 | Volume: | 53,478 |
|---|---|---|---|---|---|
| Previous Close: | 0.2500 | 52wk Range: | 0.2400 - 1.9100 | 1-Yr Rtn: | -85.12% |
Key Statistics for THERF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(11/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (CAD) (ttm) | - |
| Est. EPS (CAD) (11/2013) | -0.0100 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 15,346 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/12/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for THERF
Company Profile & Key Executives for THERF
Theratechnologies, Inc. is a specialty pharmaceutical company that discovers and develops therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. The Company's main product is being marketed in the United States for the reduction of excess abdominal fat n HIV-infected patients with lipodystrophy.
| Luc TanguayPres/CEO/Investor Relations | Christian MarsolaisSenior VP:Scientific Affairs |
| Marie-Noel ColussiVP:Finance | Jocelyn LafondVP:Legal Affairs/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
THERF News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page